News Releases - Achieve Life Sciences

News Releases

Home

Home ivps4 2017-06-16T21:39:52+00:00

News Releases

Month Year

Month Year

Investor Alerts

Sep 15, 2021

Achieve Life Sciences to Participate in Upcoming Investor Conferences
Sep 14, 2021

Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference
Sep 9, 2021

Achieve Life Sciences to Participate in Two Upcoming Investor Conferences
Aug 13, 2021

Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards
Aug 12, 2021

Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
Aug 11, 2021

Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen
Aug 3, 2021

Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
Jul 22, 2021

Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use
Jun 29, 2021

Achieve Announces Completion of Target Enrollment of 750 Subjects in Phase 3 ORCA-2 Smoking Cessation Trial of Cytisinicline

ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States
Jun 3, 2021

Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction

Show per page

Stock Info